1. Home
  2. DSS vs MBAI Comparison

DSS vs MBAI Comparison

Compare DSS & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DSS Inc.

DSS

DSS Inc.

HOLD

Current Price

$0.89

Market Cap

9.2M

ML Signal

HOLD

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.65

Market Cap

10.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DSS
MBAI
Founded
1984
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Containers/Packaging
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
10.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
DSS
MBAI
Price
$0.89
$1.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
246.8K
91.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
42.45
N/A
EPS
N/A
N/A
Revenue
$2,085,000.00
N/A
Revenue This Year
$14.93
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$1.31
52 Week High
$1.90
$3.92

Technical Indicators

Market Signals
Indicator
DSS
MBAI
Relative Strength Index (RSI) 43.99 49.74
Support Level $0.88 $1.31
Resistance Level $0.99 $1.87
Average True Range (ATR) 0.05 0.15
MACD -0.00 -0.01
Stochastic Oscillator 33.46 46.49

Price Performance

Historical Comparison
DSS
MBAI

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: